Physician profile
Amy L Marlow
NPI 1538162359
$2,816.05
in general payments reported to CMS, 2019-2025
16 companies · $526 in 2025
The $526 reported for 2025 was more than what 94% of Pediatrics providers received nationally (typical 2025 total: $96.93).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $236 · 2020: $236 · 2021: $404 · 2022: $332 · 2023: $496 · 2024: $587 · 2025: $526.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,609.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,608.64 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Supernus Pharmaceuticals, INC. | $645.98 | 2021-2025 | Qelbree, Qelbree |
| Corium, LLC | $587.43 | 2022-2025 | Azstarys |
| Ironshore Pharmaceuticals INC. | $507.96 | 2019-2024 | Jornay Pm |
| Glaxosmithkline, LLC. | $255.70 | 2019-2023 | Bexsero, Pediarix, Rotarix |
| Collegium Pharmaceutical, INC. | $163.32 | 2025 | Jornay Pm |
| Takeda Pharmaceuticals U.S.A., INC. | $155.13 | 2020-2022 | |
| Tris Pharma INC | $133.79 | 2019-2023 | Dyanavel Xr |
| Pfizer INC. | $130.06 | 2019-2025 | |
| Neurelis, INC. | $67.80 | 2020-2021 | |
| Merck Sharp & Dohme LLC | $34.83 | 2021-2025 | Enflonsia |
| Abbvie INC. | $32.57 | 2020-2023 | |
| Adlon Therapeutics L.P. | $31.88 | 2020-2021 | |
| Mayne Pharma Commercial LLC | $22.03 | 2023-2025 | |
| Sanofi Pasteur INC. | $19.14 | 2025 | |
| Genentech USA, INC. | $16.67 | 2019 |
Show all 16 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Arbor Pharmaceuticals, INC. | $11.76 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Amy Marlow listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.